Stock 688185 CANSINO BIOLOGICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company CanSino Biologics Inc. Shanghai S.E.

Equities

688185

CNE100004BM0

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
41.09 CNY -1.98% Intraday chart for CanSino Biologics Inc. -6.93% -44.86%
24/06 Cansino Biologics' Senior Management to Boost Stakeholding MT
10/06 Indonesia ramps up fight against tuberculosis amid concerns on economic impact RE

Business Summary

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Number of employees: 1,494

Sales per Business

HKD in Million2022Weight2023Weight Delta
Vaccine Products
100.0 %
1,203 100.0 % 395 100.0 % -67.20%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.1 %
945 78.8 % 378 99.1 % -60.01%
Foreign
0.9 %
254 21.2 % 3 0.9 % -98.63%

Managers

Managers TitleAgeSince
Hui Hua Mao FOU
 Founder 62 13/09/13
Tao Zhu FOU
 Founder 51 13/09/13
Xue Feng Yu CEO
 Chief Executive Officer 60 13/09/13
Dong Xu Qiu FOU
 Founder 64 13/09/13
Ming Liu DFI
 Director of Finance/CFO 43 01/21/01
Jun Qiang Li CTO
 Chief Tech/Sci/R&D Officer - -
Shou Bai Chao COO
 Chief Operating Officer 61 01/18/01
Jing Wang BRD
 Director/Board Member 42 01/12/01
Zhong Qi Shao BRD
 Director/Board Member 61 01/11/01
Jin Cui SEC
 Corporate Secretary 37 01/16/01

Members of the board

Members of the board TitleAgeSince
Shou Bai Chao COO
 Chief Operating Officer 61 01/18/01
Dong Xu Qiu FOU
 Founder 64 13/09/13
Shui Fa Gui BRD
 Director/Board Member 58 29/19/29
Xue Feng Yu CEO
 Chief Executive Officer 60 13/09/13
Tao Zhu FOU
 Founder 51 13/09/13
Zhong Qi Shao BRD
 Director/Board Member 61 01/11/01
Zhi Xiao CHM
 Chairman 45 28/19/28
Jing Wang BRD
 Director/Board Member 42 01/12/01
Jian Zhong Liu BRD
 Director/Board Member 59 29/19/29
Yuan Zhou BRD
 Director/Board Member 36 01/19/01

Shareholders

NameEquities%Valuation
Hui Hua Mao
8.988 %
11,924,700 8.988 % 31 M ¥
Xue Feng Yu
8.736 %
11,590,183 8.736 % 30 M ¥
Dong Xu Qiu
8.354 %
11,083,517 8.354 % 29 M ¥
Qiming Venture Partners Ltd.
5.666 %
7,516,538 5.666 % 20 M ¥
BlackRock Fund Advisors
2.174 %
2,884,200 2.174 % 8 M ¥
GF Fund Management Co., Ltd.
0.9621 %
1,276,400 0.9621 % 3 M ¥
Huashang Fund Management Co., Ltd.
0.7115 %
944,000 0.7115 % 2 M ¥
BlackRock Advisors (UK) Ltd.
0.6625 %
879,000 0.6625 % 2 M ¥
BlackRock (Netherlands) BV
0.5116 %
678,689 0.5116 % 2 M ¥
Zhong Qi Shao
0.5088 %
675,000 0.5088 % 2 M ¥
NameEquities%Valuation
Rongtong Fund Management Co., Ltd.
1.255 %
838,396 1.255 % 6 M ¥
Yinhua Fund Management Co., Ltd.
1.228 %
820,680 1.228 % 6 M ¥
GF Fund Management Co., Ltd.
1.062 %
709,816 1.062 % 5 M ¥
CANSINO BIOLOGICS INC.
1.003 %
670,148 1.003 % 5 M ¥
Penghua Fund Management Co., Ltd.
0.8712 %
582,090 0.8712 % 4 M ¥
Bosera Asset Management Co., Ltd.
0.8577 %
573,109 0.8577 % 4 M ¥
Lion Fund Management Co., Ltd.
0.7184 %
480,000 0.7184 % 3 M ¥
China Southern Asset Management Co., Ltd.
0.3263 %
218,027 0.3263 % 1 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.1622 %
108,372 0.1622 % 737 689 ¥
China Asset Management Co., Ltd.
0.1131 %
75,542 0.1131 % 514 215 ¥

Holdings

NameEquities%Valuation
CANSINO BIOLOGICS INC.
1.00%
 670,148 1.00% 4,561,704 $

Company contact information

CanSino Biologics, Inc.

4/F, Room 401-420, Biomedical Park 185 South Avenue

300457, Tianjin

+86 022 5821 3600

http://www.cansinotech.com
address CanSino Biologics Inc.(688185)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for CanSino Biologics Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
18.19 CNY
Average target price
25.66 CNY
Spread / Average Target
+41.10%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
+2.08% 95.18B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-4.34% 37.55B
BIOGEN INC. Stock Biogen Inc.
-10.41% 33.75B
UCB Stock UCB
+77.82% 28.2B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.61% 15.63B
INCYTE CORPORATION Stock Incyte Corporation
-3.46% 13.63B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.31% 11.5B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+184.77% 10.81B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-54.13% 9.23B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6185 Stock
  4. 688185 Stock
  5. Company CanSino Biologics Inc.